Global Drug Device Combination Product Market - Regional Analysis
Among region, North America is estimated to hold a dominant position in the global drug device combination product market over the forecast period. North America is estimated to hold 40.51% of the market share in 2030.
Global Drug Device Combination Product Market- Cross Sectional Analysis
Among products type, Drug eluting stents (DES) held a dominant position in North America region over the forecast period due to increasing number of inorganic growth strategies such as collaboration and others by the market players for product development. For instance, 13 May, 2022, Medtronic plc, a global leader in healthcare technology, announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier drug-eluting stent (DES).
Drug Device Combination Products Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients